Oncology-focused biotech Panbela Therapeutics (NASDAQ:PBLA) fell ~62% premarket Monday after announcing a public offering of common stock and warrants to raise ~$9.0 in gross proceeds. Per the terms, ...
Source LinkOncology-focused biotech Panbela Therapeutics (NASDAQ:PBLA) fell ~62% premarket Monday after announcing a public offering of common stock and warrants to raise ~$9.0 in gross proceeds. Per the terms, ...
Source Link
Comments